Latest News about NVO
Recent news which mentions NVO
Inconsistent Insurance Coverage For Weight Loss Drugs - Novo Nordisk's GLP-1s Face Hurdles Despite Health Benefits
March 18, 2024
From Benzinga
US Prescriptions Race For Weight Loss Drugs - Eli Lilly's Zepbound Overtakes Novo Nordisk's Wegovy
March 18, 2024
From Benzinga
Tickers
NVO
From Motley Fool
Tickers
NVO
From Motley Fool
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
March 17, 2024
From Motley Fool
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
March 17, 2024
From Motley Fool
Eli Lilly Taps Amazon to Deliver Its Weight Management Blockbuster. Is It Time to Buy the Pharma Stock?
March 17, 2024
From Motley Fool
From Benzinga
7 Mega-Cap Stocks That Can Turn $10,000 Into $1 Million
March 15, 2024
From InvestorPlace
Tickers
NVO
From Motley Fool
3 Weight-Loss Stocks to Buy as GLP-1 Mania Takes Hold
March 15, 2024
From InvestorPlace
From Motley Fool
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
March 15, 2024
From Motley Fool
3 Pharma Stocks to Sell in March Before They Crash & Burn
March 14, 2024
From InvestorPlace
Is WW Stock on the Brink of Bankruptcy?
March 14, 2024
From InvestorPlace
Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs
March 13, 2024
From Benzinga
Pharmaceutical Crime Jumps 50% As Criminals Seek To Capitalize Rising Tide of Counterfeit Weight-Loss Drugs
March 13, 2024
From Benzinga
From Benzinga
From Motley Fool
US Health Agency Reviews Novo Nordisk's Wegovy For Potential Use In Treating Heart Disease Patients With Obesity
March 12, 2024
From Benzinga
Gary Black Keeping Tabs On Oprah's Upcoming TV Special About Ozempic — 'Shame, Blame And The Weight Loss Revolution'
March 12, 2024
From Benzinga
From InvestorPlace
Anti-Counterfeiting Group Identifies Fake Diabetes Drug Ozempic in 16 Countries: Sparks Patient Harm Concerns
March 11, 2024
From Benzinga
Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt 'Barbell Approach'
March 11, 2024
From Benzinga
From InvestorPlace
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.